Skip to content
Screener

EPS (Diluted) at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-$0.25+43.2%
UnitedHealth Group logo
UnitedHealth GroupUNH
$6.04+61.5%
Conduent Incorporated logo
Conduent IncorporatedCNDT
-$0.76-192%
Definitive Healthcare Corp. logo
Definitive Healthcare Corp.DH
-$0.05+28.6%
Corvel logo
CorvelCRVL
$0.63+21.2%
Phreesia logo
PhreesiaPHR
$0.05+171%

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Less: net loss attributable to non-controlling interests
Net loss attributable to Claritev Corporation$(59,226)$(62,640)$(132,786)$(133,959)
Weighted average shares outstanding – Basic and Diluted16,964,96016,453,89616,830,36116,364,573
Net loss per share – Basic and Diluted$(3.49)$(3.81)$(7.89)$(8.19)
Net loss attributable to Claritev Corporation(59,226)(62,640)(132,786)(133,959)
Other comprehensive income (loss)
Change in unrealized gain (loss) on interest rate swaps, net of tax1,3967533,217(871)
Comprehensive loss$(57,830)$(61,887)$(129,569)$(134,830)

Item 1. Financial Statements

FAQ

What is Claritev Corporation's EPS (diluted)?
Claritev Corporation (CTEV) reported EPS (diluted) of -$3.49 in Q2 2026.
How has Claritev Corporation's EPS (diluted) changed year-over-year?
Claritev Corporation's EPS (diluted) increased by 8.4% year-over-year, from -$3.81 to -$3.49.
What is the long-term trend for Claritev Corporation's EPS (diluted)?
Over 4 years (2021 to 2025), Claritev Corporation's EPS (diluted) has grown at a 222.5% compound annual growth rate (CAGR), from $0.16 to -$17.30.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Claritev Corporation's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude